pdgfrα

What are the Therapeutic Strategies Targeting PDGFRα?

Given its role in various diseases, PDGFRα is a target for therapeutic intervention. Tyrosine kinase inhibitors (TKIs) such as Imatinib have been developed to inhibit PDGFRα activity. These inhibitors are used in the treatment of cancers like GISTs and offer promising avenues for managing fibrotic diseases.

Frequently asked queries:

What is PDGFRα?
Where is PDGFRα Expressed?
What are the Functions of PDGFRα?
How is PDGFRα Studied in Histology?
What are the Clinical Implications of PDGFRα?
What are the Therapeutic Strategies Targeting PDGFRα?
How Does Cerner PathNet Ensure Data Security and Compliance?
Where is Henle's Layer Located?
How Do Calicoblasts Secrete Calcium Carbonate?
What are the Key Cells Involved in Tissue Repair?
What Role Does Histology Play in Risk Assessment?
What are the Features of Simple Columnar Epithelium?
What are the Clinical Implications of MyD88 Dysfunction?
Why is the Study of Sensory Neurons Important?
What is Glycemic Management?
How Does Immunohistochemistry Contribute?
Why is Oxidative Enzyme Histochemistry Important?
What Are the Core Topics in Histology Education?
What Are Some Applications of Genomic Information in Histology?
What is the Importance of Tumor Grading and Staging?
Follow Us
Top Searches
3D bioprinting 3D Tissue Environments Cancer Diagnostics Histopathology Molecular Imaging Neurodegeneration Skin Homeostasis

Partnered Content Networks

Relevant Topics